Discover the full management transaction log of 케이바이오랩스, a publicly traded company based in South Korea. Shares are quoted on KR KR, under the oversight of DART (FSS). Market capitalisation: €27.8bn. The latest transaction was filed on 23 April 2026 — Sale. Among the most active insiders: 미래아이앤지. All data is openly available.